GLP1R and metabolic dysfunction-associated steatotic liver disease: Nevertheless, at the same time, some researchers suggest that the effect of GLP-1 receptor agonists for NAFLD treatment is attractive, especially in patients with coexisting type 2 diabetes or obesity (124).